Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Phase 2 Study of Denosumab (IND 127430, NSC 744010), a Rank Ligand Antibody, for Recurrent or Refractory Osteosarcoma |
---|---|
Full Title | Phase 2 Study of Denosumab (IND 127430, NSC 744010), a Rank Ligand Antibody, for Recurrent or Refractory Osteosarcoma |
Disease/Condition | Pediatric Hematology/Oncology |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Lisa Figueiredo |
Contact Name | Joyce Brown |
Contact Email | joycbrow@montefiore.org |
Protocol Number | IRB# 2015-5828 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Enrolling |
Adult Clinical Trial | No |
Pediatric Clinical Trial | No |
Adult, Pediatric, Both | Adult |